BCRABL1 Kinase Domain Mutation Analysis IRMA
Introduction
The BCRABL1 Kinase Domain Mutation Analysis IRMA is a specialized genetic test designed to detect mutations in the BCR-ABL1 gene, which are often associated with certain types of blood cancers, particularly Chronic Myeloid Leukemia (CML). Understanding these mutations is crucial for determining the most effective treatment strategies for patients. This test plays a vital role in guiding oncologists in tailoring therapy to achieve optimal outcomes.
What the Test Measures
This test specifically measures the presence of mutations in the kinase domain of the BCR-ABL1 gene. These mutations can lead to resistance against certain targeted therapies, making it essential to identify them for proper management of the disease.
Who Should Consider This Test
Patients diagnosed with Chronic Myeloid Leukemia or those experiencing treatment resistance should consider this test. Symptoms that may prompt testing include:
- Fatigue
- Unexplained weight loss
- Night sweats
- Frequent infections
- Easy bruising or bleeding
Additionally, individuals with a family history of blood disorders may also benefit from this analysis.
Benefits of Taking the Test
- Identifies mutations that may affect treatment efficacy.
- Guides oncologists in personalizing treatment plans.
- Provides critical information for monitoring disease progression.
- Helps in predicting potential resistance to therapies.
Understanding Your Results
Results from the BCRABL1 Kinase Domain Mutation Analysis IRMA can help in understanding the genetic landscape of the disease. Positive results may indicate the presence of mutations that require a change in treatment strategy, while negative results may suggest that current therapies are still effective. It is essential to discuss your results with your healthcare provider to understand their implications fully.
Test Information
| Test Name | Price (KSh) |
|---|---|
| Discount Price | 30,000 KSh |
| Regular Price | 40,000 KSh |
Sample Collection and Pre-Test Instructions
The BCR-ABL1 Kinase Domain Mutation Analysis IRMA requires a sample type of bone marrow or peripheral blood, which should be transported immediately. It is important to note that this test can only be conducted with a Doctor’s prescription, excluding cases related to surgery, pregnancy, or individuals planning to travel abroad.
Branches and Booking
We have branches across all major cities in Kenya, making it convenient for you to access our services. To book the BCRABL1 Kinase Domain Mutation Analysis IRMA test, please call or WhatsApp us at +254711564616. Don’t wait—take a proactive step towards your health today!
